ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,783.00
-0.71%
S&P ASX All Technology
3,113.80
0.20%
Brent Oil
84.185
0.00%
US Dollar vs AUD
1.50427
-0.05%
Bitcoin
61,468.71
-0.55%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LLY
DateTimeSourceHeadlineSymbolCompany
26/06/202400:00PR Newswire (US)Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteriaNYSE:LLYEli Lilly and Co
25/06/202401:30PR Newswire (US)Lilly Declares Third-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
24/06/202421:00IH Market NewsUPS Divests Coyote Logistics in $1.025 Billion Deal with RXO, Under Armour Agrees to $434 million Settlement, and More NewsNYSE:LLYEli Lilly and Co
22/06/202405:49PR Newswire (US)Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolutionNYSE:LLYEli Lilly and Co
19/06/202406:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
18/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
15/06/202404:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
12/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
11/06/202421:11IH Market NewsFDA Panel Supports Eli Lilly’s Donanemab, Rio Tinto Expands Stake in Boyne Smelters, and More NewsNYSE:LLYEli Lilly and Co
11/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
08/06/202423:03PR Newswire (US)Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeksNYSE:LLYEli Lilly and Co
08/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
08/06/202404:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
07/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
06/06/202404:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
05/06/202421:48Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
05/06/202421:45PR Newswire (US)Lilly announces departure of Anat Ashkenazi, chief financial officerNYSE:LLYEli Lilly and Co
05/06/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/06/202423:00PR Newswire (US)Melissa Seymour to join Lilly as executive vice president of Global QualityNYSE:LLYEli Lilly and Co
04/06/202408:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
04/06/202408:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
04/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/06/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Your Recent History

ASX
WBC
Westpac Banking
ASX
AMP
AMP
NASDAQ
AAPL
Apple
ASX
MQG
Macquarie
ASX
WOW
Woolworths
NYSE
MRK
Merck
ASX
BHP
BHP
ASX
CBA
Commonwealth Bank Of Aus...
COIN
BTCUSD
Bitcoin
ASX
WPL
Woodside Petroleum
NYSE
KO
Coca Cola
ASX
QBE
QBE Insurance
ASX
XJO
S&P ASX 200
NYSE
DIS
Walt Disney
ASX
FMG
Fortescue
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved